Around a core strength in pharmaceutical sector IP, Olivares has built a substantial and wider-reaching practice across life sciences in Mexico, representing an outstanding choice in rights protection, but also being reliable counsel for a range of commercial matters in the related industries. On the regulatory side, life sciences research and development projects are a standout strength, and the practice has been a fixture in matters that have shaped Mexico’s pharmaceuticals regulatory framework. The aforementioned IP expertise of the firm bears fruit in its patent work, including patent term corrections and patent linkage, while on the trade mark side, the firm has innovated a database system of the Mexican Trademark Office and regulatory agency COFEPRIS that predicts whether a drug will gain the authorisation of its commercial name. Administrative compliance is a further strength, while in transactional matters the team has become increasingly well versed in assisting with the development, consolidation, and expansion of its clients' Mexican operations. Gustavo Alcocer oversees the corporate, transactional and financing aspects of the practice; Alejandro Luna excels in litigation, with standout expertise in patent matters; Armando Arenas heads the anti-piracy/counterfeiting practice in medicines, while also leading on civil litigation matters; and Rommy Morales is a specialist in patent prosecution, IP litigation, and plant variety protection. The above-mentioned lawyers jointly coordinate the life sciences practice as a whole. Further names to note include senior associates Ingrid Ortiz and Karla Olvera, who both excel in litigation; and Mauricio Samano, a patent expert.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Without a doubt, Olivares has always stood out for being an innovative firm in the pharmaceutical sector. They always think about how to help companies and obtain innovative resolutions that serve as a spearhead to recognize important rights of companies.'

Key clients

  • Roche
  • Biogen
  • GSK
  • Novartis
  • Lilly
  • Abbvie
  • Sanofi
  • Pfizer
  • Astellas
  • Anheuser-Busch InBev

Lawyers

Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Gustavo Alcocer, Alejandro Luna, Armando Arenas, Rommy Morales